Is Pfizer Stock a Buy?
Pfizer (NYSE: PFE) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on hopes for its coronavirus vaccine, new sources of growth haven't led to equally outsized windfalls.
But for investors, it could still be a great pickup once a few of the loftier expectations about its future are safely in check. Let's start by hearing from the bears about why the stock isn't a buy, and then look at the other side's argument.
Under normal conditions, one might expect that a big pharma business, with a large portfolio of essential drugs and a recent run of best-selling medicines like the Comirnaty coronavirus vaccine, would be booming. In such a scenario, the investing thesis would be obvious -- buy the stock, because the company has a knack for making it go up consistently over time by successfully developing the right drugs for the right markets.
Source Fool.com
Pfizer Inc. Stock
The stock is one of the favorites of our community with 29 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a positive potential of 47.06% compared to the current price of 27.88 € for Pfizer Inc..